By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CoMentis, Inc. 

Corporate Headquarters
280 Utah Avenue, Suite 275
South San Francisco  California  94080  U.S.A.
Phone: 650-869-7600 Fax: 650-869-7626


SEARCH JOBS








Company News
CoMentis, Inc. And Anvyl Announce The Initiation Of Clinical Trials For APN1125 For The Treatment Of Schizophrenia 1/9/2015 10:11:22 AM
Astellas Pharma Inc. (ALPMY), CoMentis, Inc. Terminate Alzheimer's Agreement 10/17/2014 6:24:11 AM
CoMentis, Inc. and Anvyl Announce Formation of Alpharmagen, a Joint Venture to Explore Nicotinic Modulators 6/14/2013 8:43:54 AM
Terence A. Kelly, Ph.D., Joins CoMentis, Inc. as Senior Vice President for Discovery and Preclinical Development 7/12/2010 10:59:55 AM
CoMentis, Inc. and Astellas Pharma Inc. to Present Alzheimer's Disease Research at International Conference on Alzheimer's Disease (ICAD) 7/28/2008 9:36:34 AM
New Alzheimer's Treatment Completes First Phase Of Testing 1/28/2008 7:42:09 AM
CoMentis, Inc. Announces Proof-of-Activity Data From Its Phase I Study of Disease-Modifying Alzheimer's Disease Therapy 1/8/2008 9:57:57 AM
CoMentis, Inc. Announces Appointment of John L. Higgins to Board of Directors 1/8/2008 9:56:48 AM
Juvenile Diabetes Research Foundation Partners with CoMentis, Inc. for Diabetic Macular Edema Clinical Trial 9/20/2007 1:30:00 PM
Juvenile Diabetes Research Foundation Partners With CoMentis, Inc. for Diabetic Macular Edema Clinical Trial 9/20/2007 8:41:25 AM
12
//-->